Special DDS capabilities-Mebiopharm > Company Outline
HomeSitemapNotes for UsageInquiry日本語
Introduction
Management Philosophy
Business Plan
Board Members
History
Research & Development
Investor Relations
Recruit
Map
   
Company Outline

 

 ■Corporate Profile

Name Mebiopharm Co., Ltd.
Established: July 15, 2002
Capital fund: JPY 1,466.97 million

 ■Board Members


CEO:

Mr. Tadashi Fujisawa

 ( Former GlaxoSmithKline Marketing Div.; New Product Div. )

Director:

Dr. Kazuo Maruyama

 (Professor, Department of Biopharmaceutics, School of Pharmaceutical Sciences, Teikyo University)

Director:

Dr. Donghyun Kim

 (Former Baxter Non-clinical Division, R&D

Director:

Mr. Nobuyuki Yamagata

 (Former Aventis -Pharma

Director:

Mr. Kazushi Okada

 (Former Shiratori Pharmaceuticals Inc.

Director:

Mr. Koichi Kageyama

   

 

Auditor:

Dr. Tadayuki Ibuki

 (Former ASAHI KASEI Corporation, General Manager)

Auditor:

Mr. Ryoichi Nishizawa

 (Certified Public Accountant, Licensed Tax Accountant)

Auditor:

Dr. Yoshiki Suzuki

 (Lecturer, the Faculty of Pharmaceutical Sciences, Hoshi University)

 

Advisor:

Dr. Charles M. Johnson, III, M.D., FACS, FAAP

 (Private Practice: Otolaryngology, Pediatric Otolaryngology, Head and Neck Surgical Oncology and Otolaryngologic Allergy, M.D., The Johns Hopkins University)

 

 

   ■Major Shareholders

 Mr. Tadashi Fujisawa (Founder)
 Dr. Masazumi Eriguchi (Former Professor, Intelectual Property Division, Research Center for Advanced Science and Technology, The University of Tokyo)
 Dr. Hironobu Yanagie (Associate Professor, Research Center for Advanced Science and Technology, The University of Tokyo)
 Dr. Kazuo Maruyama Professor, Department of Biopharmaceutics School of Pharmaceutics School of Pharmaceutical Sciences, Teikyo University)
 Dr. Morimasa Sekiguchi (Former professor of Surgery, The Institute of Medical Science, The University of Tokyo)
 
 NIF SMBC Ventures Co., Ltd.
 JAFCO Co., Ltd.
 The University of Tokyo Edge Capital Co., Ltd
 Mizuho Capital Co., Ltd
 Japan Asia Investment Co., Ltd
 TRANS-SCIENCE INC.
 RESONA Capital Co., Ltd
 ORIX Capital Corporation
 Meiji Capital Co., Ltd
 Nikko antfactory K.K.
 Tokio Marine & Nichido Fire Insurance Co., Ltd.
 Nomura Research & Advisory Co., Ltd.
 Shinsei Bank , Limited

 

Copyright© 2005-2007 Mebiopharm Co., Ltd. All Rights Reserved.